Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCI.PRA
1751
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
| $5.3M | ﹤0.01% |
4,879
-2,564
| -34% | -$2.78M |
|
1752
Pool Corp
POOL
$7.5B
| $5.29M | ﹤0.01% |
31,723
+12,258
| +63% | +$1.98M |
|
1753
CALL
Fidelity National Information Services
FIS
$22.1B
| $5.29M | ﹤0.01% |
48,500
| – | – |
|
1754
PUT
Alaska Air
ALK
$5.58B
| $5.29M | ﹤0.01% |
76,800
-9,100
| -11% | -$590K |
|
1755
PUT
Xerox
XRX
$425M
| $5.29M | ﹤0.01% |
195,875
+5,000
| +3% | +$132K |
|
1756
PUT
Skyworks Solutions
SWKS
$10.6B
| $5.28M | ﹤0.01% |
58,200
-10,900
| -16% | -$1.02M |
|
1757
Simpson Manufacturing
SSD
$8.16B
| $5.27M | ﹤0.01% |
72,687
+28,458
| +64% | +$2.02M |
|
1758
Apple Hospitality REIT
APLE
$3.82B
| $5.26M | ﹤0.01% |
300,968
+29,069
| +11% | +$516K |
|
|
NVO
1759
Novo Nordisk
NVO
$209B
| $5.25M | ﹤0.01% |
222,748
-106,328
| -32% | -$2.59M |
|
1760
CALL
ProShares Ultra Bloomberg Crude Oil
UCO
$385M
| $5.25M | ﹤0.01% |
23,344
-2,384
| -9% | -$466K |
|
1761
PUT
Helmerich & Payne
HP
$3.71B
| $5.23M | ﹤0.01% |
76,100
-64,400
| -46% | -$4.11M |
|
1762
RenaissanceRe
RNR
$13.4B
| $5.23M | ﹤0.01% |
39,123
+6,678
| +21% | +$862K |
|
|
PDCE
1763
DELISTED
PDC Energy, Inc.
PDCE
| $5.21M | ﹤0.01% |
106,536
-17,348
| -14% | -$961K |
|
1764
Kinross Gold
KGC
$32.8B
| $5.21M | ﹤0.01% |
1,930,493
+274,651
| +17% | +$889K |
|
1765
PUT
T. Rowe Price
TROW
$24.3B
| $5.21M | ﹤0.01% |
47,700
+45,800
| +2,411% | +$5.3M |
|
|
RDS.A
1766
PUT
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $5.2M | ﹤0.01% |
76,300
-4,700
| -6% | -$314K |
|
|
NBIS
1767
PUT
Nebius Group N.V.
NBIS
$47.7B
| $5.2M | ﹤0.01% |
158,000
-150,100
| -49% | -$5.08M |
|
|
ENLC
1768
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $5.19M | ﹤0.01% |
315,693
+10,698
| +4% | +$178K |
|
1769
PUT
Fastenal
FAST
$59.5B
| $5.19M | ﹤0.01% |
358,000
+18,000
| +5% | +$256K |
|
1770
Nu Skin
NUS
$267M
| $5.19M | ﹤0.01% |
62,959
+16,621
| +36% | +$1.32M |
|
1771
Melco Resorts & Entertainment
MLCO
$2.14B
| $5.18M | ﹤0.01% |
244,843
+66,798
| +38% | +$1.55M |
|
|
ESV
1772
DELISTED
Ensco Rowan plc
ESV
| $5.18M | ﹤0.01% |
153,333
-239,892
| -61% | -$6.86M |
|
|
HRC
1773
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $5.17M | ﹤0.01% |
54,791
+10,357
| +23% | +$972K |
|
1774
Spire
SR
$4.85B
| $5.17M | ﹤0.01% |
70,251
+51,810
| +281% | +$3.83M |
|
|
ONC
1775
PUT
BeOne Medicines Ltd
ONC
$39.4B
| $5.17M | ﹤0.01% |
+30,000
| New | +$5.04M |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.